Stay updated with breaking news from Errita Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOGOR (West Java): The Malaysian government is committed to ensuring that investments made by the Armed Forces Fund Board (LTAT) in domestic and inter...
KUALA LUMPUR: Pharmaniaga Bhd is looking to expand its market presence to the United Kingdom (UK), Turkey as well as the Middle East and North Africa (MENA) in the next two to three years, while also strengthening its presence in Indonesia.
KUALA LUMPUR, June 13 — Pharmaniaga Bhd is looking to expand its market presence to the United Kingdom (UK), Turkey as well as the Middle East and North Africa (MENA) in the next...
PHARMANIAGA Bhd’s Indonesia-listed logistics and distribution arm PT Millennium Pharmacon International Tbk (MPI) is looking at inorganic growth opportunities such as acquisitions and joint ventures (JV) to accelerate its growth. “We are approaching a few companies. Some of them are also our principals. We cannot reveal their names, but we are trying to work with them because some of these companies have good products and good marketing teams, but they do not have the funds (to grow),” MPI president director Ahmad Abu Bakar tells The Edge in a virtual interview.
Pharmaniaga Bhd, which posted record profit and revenue for the financial year ended Dec 31, 2021 (FY21), expects to repeat this feat in FY22, driven by robust vaccine demand, better contribution from Indonesia and over-the-counter (OTC) products.